Donanemab

Records for this ingredient, by country (identity only).

ATC N06DX05 · 11 markets · 12 records

Donanemab 11 markets · 12 records Forms
Filters
MarketAU 2US 1GB 1CA 1SG 1CN 1MX 1TW 1HK 1JP 1EU 1

AU 2 records · 1 shown of 1 Source TGA、TGA CMI repository (consumer medic · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 17.5 mg/mL per mL / per unit basis not statedinjectionKISUNLA donanemab 350 mg/20 mL concentrated solution for intravenous infusion vial unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Kisunla ×3

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

  • 17.5 mg per mL / per unit basis not statedinjectionKisunla

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

  • 350 mg/20 mLinjectionKisunla 350mg/20ml concentrate for solution for infusion vials also in SG·CN·TW
    +1Other 1 marketsJP

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

  • 17.5 mg per mL / per unit basis not statedliquidKisunla

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

  • 350 mg/20 mLinjectionLormalzi Concentrate for Solution for Infusion 350mg/20mL also in GB·CN·TW
    +1Other 1 marketsJP

CN 1 records · 1 shown of 1 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

MX 1 records · 0 shown of 0 Source COFEPRIS · Data as of annual · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Kisunla ×3

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

TW 1 records · 1 shown of 1 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22

  • 350 mg/20 mLinjectionKisunla欣智樂注射劑 350毫克/20毫升 also in GB·SG·CN
    +1Other 1 marketsJP

HK 1 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名KISUNLA CONCENTRATE FOR SOLUTION FOR INFUSION 350MG/20ML ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

JP 1 records · 1 shown of 1 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

  • 350 mg/20 mLinjectionケサンラ点滴静注液350mg also in GB·SG·CN
    +1Other 1 marketsTW

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Kisunla ×3

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.